Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
111,111,111
-
Number of holders
-
242
-
Total 13F shares, excl. options
-
91,742,662
-
Shares change
-
-3,167,714
-
Total reported value, excl. options
-
$1,185,376,041
-
Value change
-
-$65,862,677
-
Put/Call ratio
-
19.62%
-
Number of buys
-
130
-
Number of sells
-
-122
-
Price
-
$12.92
Significant Holders of NovoCure Ltd - Common Stock (NVCR) as of Q3 2025
301 filings reported holding NVCR - NovoCure Ltd - Common Stock as of Q3 2025.
NovoCure Ltd - Common Stock (NVCR) has 242 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 91,742,662 shares
of 111,111,111 outstanding shares and own 82.57% of the company stock.
Largest 10 shareholders include FMR LLC (16,769,878 shares), BlackRock, Inc. (13,947,558 shares), VANGUARD GROUP INC (10,455,841 shares), Soleus Capital Management, L.P. (9,644,872 shares), STATE STREET CORP (2,610,688 shares), GEODE CAPITAL MANAGEMENT, LLC (2,474,988 shares), Capital World Investors (2,000,000 shares), Nuveen, LLC (1,707,842 shares), Quantinno Capital Management LP (1,522,168 shares), and MILLENNIUM MANAGEMENT LLC (1,335,490 shares).
This table shows the top 242 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.